This summary covers recent developments in the health sector, including studies on thyroid medications and asthma drugs, ...
Biden's new proposal would significantly expand access to anti-obesity drugs such as Ozempic and Wegovy. Without insurance coverage, the drugs can cost as much as $1,000 a month. Lawmakers previously ...
The Biden administration announced Tuesday it’s reinterpreting federal law to allow Medicare and Medicaid patients access to ...
Health and Human Services (HHS) has unveiled a proposal to expand Medicare and Medicaid coverage to include weight loss drugs ...
A new HHS rule would require Medicare and Medicaid to cover drugs like Wegovy or Zepbound for a large segment of Americans.
Data gathered from the Central Disease Center and the American Diabetes highlights a health crisis in Arkansas.
16h
The CMS estimated that coverage of the weight-loss drugs will cost the federal government about $25 billion for Medicare and ...
It’s unclear what impact a change in presidential administration will have on the proposal to widen access for those with obesity.
Men with heart risk factors tend to lose their brain health more quickly than women with similar heart risks, a new study ...
The Biden administration wants to expand coverage of anti-obesity medications to millions on Medicare, Medicaid.
A new Biden administration proposal could allow millions of Americans with obesity to access weight-loss drugs like Wegovy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback